Financial Counselors Inc. boosted its position in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 0.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 145,139 shares of the pharmacy operator’s stock after buying an additional 1,266 shares during the period. Walgreens Boots Alliance makes up about 0.7% of Financial Counselors Inc.’s investment portfolio, making the stock its 29th largest position. Financial Counselors Inc.’s holdings in Walgreens Boots Alliance were worth $12,086,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Canada Pension Plan Investment Board raised its position in shares of Walgreens Boots Alliance by 602.0% in the first quarter. Canada Pension Plan Investment Board now owns 6,665,630 shares of the pharmacy operator’s stock worth $561,513,000 after buying an additional 5,716,161 shares in the last quarter. Boston Partners raised its position in shares of Walgreens Boots Alliance by 5,790.4% in the second quarter. Boston Partners now owns 3,158,410 shares of the pharmacy operator’s stock worth $263,001,000 after buying an additional 3,104,790 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Walgreens Boots Alliance by 9.7% in the first quarter. Wellington Management Group LLP now owns 26,167,061 shares of the pharmacy operator’s stock worth $2,204,313,000 after buying an additional 2,317,093 shares in the last quarter. USS Investment Management Ltd bought a new position in shares of Walgreens Boots Alliance during the first quarter worth $129,760,000. Finally, Ameriprise Financial Inc. raised its position in shares of Walgreens Boots Alliance by 47.1% in the second quarter. Ameriprise Financial Inc. now owns 3,924,033 shares of the pharmacy operator’s stock worth $326,755,000 after buying an additional 1,256,547 shares in the last quarter. Institutional investors and hedge funds own 59.75% of the company’s stock.

Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded down 0.81% during mid-day trading on Monday, hitting $80.83. 1,952,197 shares of the stock were exchanged. The company has a 50 day moving average of $81.49 and a 200 day moving average of $81.22. Walgreens Boots Alliance Inc. has a 12-month low of $71.50 and a 12-month high of $95.74. The firm has a market cap of $87.48 billion, a P/E ratio of 27.93 and a beta of 1.01.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, July 6th. The pharmacy operator reported $1.18 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.14 by $0.04. Walgreens Boots Alliance had a return on equity of 15.56% and a net margin of 2.70%. The business earned $29.50 billion during the quarter. During the same quarter last year, the company earned $1.02 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 2.4% compared to the same quarter last year. On average, equities analysts anticipate that Walgreens Boots Alliance Inc. will post $4.51 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, September 12th. Stockholders of record on Friday, August 19th were paid a dividend of $0.375 per share. This represents a $1.50 annualized dividend and a dividend yield of 1.84%. The ex-dividend date was Wednesday, August 17th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. Walgreens Boots Alliance’s dividend payout ratio is 51.90%.

A number of equities analysts recently weighed in on the stock. Leerink Swann restated an “outperform” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research report on Monday. Bank of America Corp. restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, June 13th. Barclays PLC upped their price target on shares of Walgreens Boots Alliance from $76.00 to $79.00 and gave the company an “equal weight” rating in a research note on Thursday, July 7th. Evercore ISI reaffirmed a “buy” rating and set a $93.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, July 7th. Finally, Jefferies Group reaffirmed a “neutral” rating on shares of Walgreens Boots Alliance in a research note on Thursday, July 7th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. Walgreens Boots Alliance presently has an average rating of “Buy” and an average target price of $93.13.

In other news, Director William C. Foote sold 2,067 shares of the company’s stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $81.35, for a total transaction of $168,150.45. Following the completion of the sale, the director now owns 26,690 shares in the company, valued at $2,171,231.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Kathleen Wilson-Thompson sold 29,695 shares of the company’s stock in a transaction that occurred on Friday, July 8th. The stock was sold at an average price of $81.03, for a total value of $2,406,185.85. The disclosure for this sale can be found here. Insiders own 21.10% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.